| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |